BiotechTube

NISE

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Knee Osteoarthritis

Conditions

Knee Osteoarthritis

Trial Timeline

Mar 1, 2011 → Aug 1, 2013

NCT ID
NCT02922712

About NISE

NISE is a approved stage product being developed by Dr. Reddy's Laboratories for Knee Osteoarthritis. The current trial status is completed. This product is registered under clinical trial identifier NCT02922712. Target conditions include Knee Osteoarthritis.

What happened to similar drugs?

10 of 20 similar drugs in Knee Osteoarthritis were approved

Approved (10) Terminated (0) Active (10)
✅Capsaicin Topical SolutionAstellas PharmaApproved
✅ImrecoxibJiangsu Hengrui MedicineApproved
✅celecoxibPfizerApproved
✅Ibuprofen + Placebo + CelecoxibPfizerApproved
✅Celecoxib + Naproxen + PlaceboPfizerApproved
✅Celecoxib + PlaceboPfizerApproved
✅Ibuprofen + celecoxibPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02922712ApprovedCompleted

Competing Products

20 competing products in Knee Osteoarthritis

See all competitors
ProductCompanyStageHype Score
NISELATDr. Reddy's LaboratoriesPre-clinical
23
LY2828360 + PlaceboEli LillyPhase 2
35
UBX0101 or placeboUnity BiotechnologyPre-clinical
8
UBX0101Unity BiotechnologyPhase 1
19
UBX0101Unity BiotechnologyPhase 2
25
UBX0101Unity BiotechnologyPhase 1
19
YH23537 + Celecoxib + YH23537 placeboYuhanPhase 2
35
YM150 + WarfarinAstellas PharmaPhase 2
35
ASP7962 + Naproxen + PlaceboAstellas PharmaPhase 2
35
Capsaicin Topical SolutionAstellas PharmaApproved
43
CGS-200-1 + CGS-200-5 + CGS-200 VehicleAstellas PharmaPhase 2
35
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + PlaceboSun PharmaceuticalPhase 2
35
Duloxetine + PlaceboShionogiPhase 3
40
DuloxetineShionogiPhase 3
40
V120083 + Naproxen + PlaceboShionogiPhase 2
35
ONO-4474 + Placebo matching ONO-4474Ono PharmaceuticalPhase 2
27
Duloxetine + PlaceboEli LillyPhase 3
40
Duloxetine (DLX) + Placebo (PLA)Eli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40
Placebo + LY545694 49 mg + LY545694 105 mgEli LillyPhase 2
35